Neuromodulator Comparison · Saratoga Springs, Utah
Xeomin vs Botox vs Letybo vs Jeuveau: an injector's honest comparison
All three are FDA-approved botulinum toxin type A treatments that soften expression lines the same fundamental way. The differences that actually matter are formulation, track record, and price. Vesta Aesthetics carries Xeomin and Letybo, injected personally by Ali Claunch, NP-C, with published member pricing from $9.45 per unit.
Four proven toxins, four different stories.
Botox (onabotulinumtoxinA) is the original, FDA-approved for cosmetic use since 2002, and remains the name most patients know. Xeomin (incobotulinumtoxinA) is a uniquely purified toxin with no complexing proteins, which may matter for patients planning years of consistent treatment. Letybo (letibotulinumtoxinA) is the newest US arrival, FDA-approved in 2024, after years as the leading toxin in South Korea. Jeuveau (prabotulinumtoxinA), FDA-approved in 2019, was the first toxin launched purely for aesthetics; it is built on a 900 kDa complex similar to Botox and doses on the same unit convention. In head-to-head studies at equivalent dosing, these toxins perform comparably on efficacy and duration. The choice comes down to your history, your goals, and value.
The comparison, in one table.
| Xeomin | Botox | Letybo | Jeuveau | |
|---|---|---|---|---|
| Active molecule | IncobotulinumtoxinA | OnabotulinumtoxinA | LetibotulinumtoxinA | PrabotulinumtoxinA |
| US cosmetic approval | 2011 | 2002 | 2024 | 2019 |
| Formulation note | Naked toxin, no complexing proteins; may lower theoretical resistance risk over years of treatment | Contains accessory proteins; the most studied toxin in the world | Conventional formulation; market leader in South Korea with millions of treatments | 900 kDa complex similar to Botox; the first aesthetics-only brand |
| Typical onset | 3 to 5 days | 3 to 5 days | 3 to 5 days | 2 to 4 days |
| Typical duration | 3 to 4 months | 3 to 4 months | 3 to 4 months | 3 to 4 months |
| At Vesta | Carried; member pricing from $10.35/unit | The benchmark most patients arrive from; switching is seamless at equivalent units | Carried; member pricing from $9.45/unit | Carried; pricing reviewed at consultation |
Onset and duration are typical ranges; individual response varies with dose, anatomy, and treatment history. Standard single-visit pricing is available to non-members and confirmed at your consultation.
How Ali decides which to use.
Most comparison articles are written by marketers. This one is written from the treatment chair. Ali injects both Xeomin and Letybo weekly and recommends between them based on three things: treatment history (patients who have used high cumulative doses for years are often steered toward Xeomin's purified formulation), response pattern (how your muscles answered previous treatments, including Botox elsewhere), and value (Letybo delivers trial-proven results at the most accessible published price floor in our studio, from $9.45 per unit for members).
If you are currently a Botox patient elsewhere, switching is routine. Dosing converts at approximately one-to-one units for Xeomin and Letybo, and your first visit at Vesta begins with a $75 consultation where Ali maps your anatomy and history before recommending anything.
Xeomin, Botox, Letybo & Jeuveau FAQs.
Is Xeomin as effective as Botox?
Yes. Head-to-head clinical studies show comparable efficacy and duration for frown lines at equivalent dosing. The practical difference is formulation: Xeomin carries no complexing proteins, which may reduce the theoretical risk of resistance with long-term use.
What is Letybo, and is it FDA approved?
Letybo received FDA approval in 2024 for moderate to severe frown lines after years as South Korea's leading neuromodulator. It entered the US as a newer, value-priced option backed by large clinical trials.
What is Jeuveau, and how does it compare?
Jeuveau (prabotulinumtoxinA) is an FDA-approved neuromodulator, cleared in 2019 as the first toxin brought to the US purely for aesthetics. Structurally it is a 900 kDa complex similar to Botox and uses the same unit dosing convention, with comparable onset and 3 to 4 month duration. Vesta carries Jeuveau alongside Xeomin and Letybo; Ali recommends between them based on your treatment history and anatomy, and pricing is reviewed at your consultation.
Which lasts longer?
No major clinical evidence shows a consistent duration advantage for any of the three at equivalent dosing. Expect roughly 3 to 4 months, with your personal response pattern mattering more than the brand.
What does treatment cost at Vesta?
Member pricing starts at $9.45 per unit for Letybo and $10.35 per unit for Xeomin, with standard single-visit rates available to everyone. Care begins with a $75 initial consultation where your exact per-visit quote is confirmed.
Can I do this through telehealth?
No. Injections are performed in person at our Saratoga Springs, Utah studio. Vesta telehealth covers wellness services such as peptide therapy, medical weight loss, and hormone optimization across Utah, Arizona, and Idaho.
Ready for a recommendation built on your anatomy?
Every neuromodulator visit at Vesta is performed personally by Ali Claunch, NP-C. Start with a $75 consultation at our Saratoga Springs studio.
Explore Neuromodulators at VestaAvailability updates & treatment insights
Subscribe for availability updates, announcements, and treatment insights. For Utah, Arizona & Idaho patients, unsubscribe any time.
Your plan starts with a $75 initial consultation
Meet one-on-one with Ali Claunch, NP-C through a HIPAA compliant telehealth consultation. We review your goals, health history, and labs, then build a personalized treatment plan. Caring for patients across Utah, Arizona, and Idaho, with in-clinic visits in Saratoga Springs.
Follow-up visits are included with an active membership. À la carte patients schedule a $75 follow-up consult at least every 90 days while on therapy.
Schedule a ConsultationA Note on Compounded Medications and FDA Oversight
Compounded peptides, GLP-1 medications, hormone therapies, NAD+ preparations, and other prescription items dispensed through Vesta Aesthetics are prepared by licensed 503A compounding pharmacies for individual patients pursuant to a valid prescription from Ali Claunch, NP-C, following a personalized clinical evaluation. Compounded medications are not FDA-approved. The FDA does not evaluate compounded preparations for safety, efficacy, or potency. Vesta Aesthetics operates in compliance with FDA regulations governing 503A patient-specific compounding and does not stock, resell, or distribute medications outside this framework. If the FDA changes guidance, restricts, or removes access to any compounded preparation, Vesta will discontinue that preparation in alignment with federal regulation.
Information on this site is educational and is not a substitute for individualized medical advice, diagnosis, or treatment. Outcomes vary by patient. No specific clinical result is promised or guaranteed. Use of any prescription medication carries risk; please review all risks with your provider before beginning therapy. Vesta Aesthetics is a self-pay medical practice and does not bill insurance. See our 503A Promise for full sourcing detail.